These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25633417)

  • 1. Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia.
    Meek TH; Dorfman MD; Matsen ME; Fischer JD; Cubelo A; Kumar MR; Taborsky GJ; Morton GJ
    Diabetes; 2015 Jul; 64(7):2376-87. PubMed ID: 25633417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Uncontrolled Diabetes, Hyperglucagonemia and Ketosis Result From Deficient Leptin Action in the Parabrachial Nucleus.
    Meek TH; Matsen ME; Faber CL; Samstag CL; Damian V; Nguyen HT; Scarlett JM; Flak JN; Myers MG; Morton GJ
    Endocrinology; 2018 Apr; 159(4):1585-1594. PubMed ID: 29438473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BDNF action in the brain attenuates diabetic hyperglycemia via insulin-independent inhibition of hepatic glucose production.
    Meek TH; Wisse BE; Thaler JP; Guyenet SJ; Matsen ME; Fischer JD; Taborsky GJ; Schwartz MW; Morton GJ
    Diabetes; 2013 May; 62(5):1512-8. PubMed ID: 23274899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressive effect of vasopressin on ketosis in diabetic rats.
    Harano A; Hidaka H; Kojima H; Harano Y; Shigeta Y
    Horm Metab Res; 1992 Jan; 24(1):5-9. PubMed ID: 1612560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin deficiency causes insulin resistance induced by uncontrolled diabetes.
    German JP; Wisse BE; Thaler JP; Oh-I S; Sarruf DA; Ogimoto K; Kaiyala KJ; Fischer JD; Matsen ME; Taborsky GJ; Schwartz MW; Morton GJ
    Diabetes; 2010 Jul; 59(7):1626-34. PubMed ID: 20424233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.
    Hendarto H; Inoguchi T; Maeda Y; Ikeda N; Zheng J; Takei R; Yokomizo H; Hirata E; Sonoda N; Takayanagi R
    Metabolism; 2012 Oct; 61(10):1422-34. PubMed ID: 22554832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic autography in uncontrolled experimental diabetes and its relationships to insulin and glucagon.
    Amherdt M; Harris V; Renold AE; Orci L; Unger RH
    J Clin Invest; 1974 Jul; 54(1):188-93. PubMed ID: 4834889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanoparticle delivery of glucagon receptor siRNA improves glucose homeostasis in mouse models of diabetes.
    Neumann UH; Ho JSS; Chen S; Tam YYC; Cullis PR; Kieffer TJ
    Mol Metab; 2017 Oct; 6(10):1161-1172. PubMed ID: 29031717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production.
    Fisher SJ; Kahn CR
    J Clin Invest; 2003 Feb; 111(4):463-8. PubMed ID: 12588884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of streptozotocin-induced diabetes on renal ornithine decarboxylase activity.
    Levine JH; Buse MG; Leaming AB; Raskin P
    Diabetes; 1980 Jul; 29(7):532-5. PubMed ID: 6445842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
    Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
    Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia.
    Gu W; Yan H; Winters KA; Komorowski R; Vonderfecht S; Atangan L; Sivits G; Hill D; Yang J; Bi V; Shen Y; Hu S; Boone T; Lindberg RA; Véniant MM
    J Pharmacol Exp Ther; 2009 Dec; 331(3):871-81. PubMed ID: 19720878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of melanocortin signaling in neuroendocrine and metabolic actions of leptin in male rats with uncontrolled diabetes.
    Meek TH; Matsen ME; Damian V; Cubelo A; Chua SC; Morton GJ
    Endocrinology; 2014 Nov; 155(11):4157-67. PubMed ID: 25137027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats.
    Cani PD; Daubioul CA; Reusens B; Remacle C; Catillon G; Delzenne NM
    J Endocrinol; 2005 Jun; 185(3):457-65. PubMed ID: 15930172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.
    Sakurai H; Dobbs RE; Unger RH
    Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.
    Sloop KW; Cao JX; Siesky AM; Zhang HY; Bodenmiller DM; Cox AL; Jacobs SJ; Moyers JS; Owens RA; Showalter AD; Brenner MB; Raap A; Gromada J; Berridge BR; Monteith DK; Porksen N; McKay RA; Monia BP; Bhanot S; Watts LM; Michael MD
    J Clin Invest; 2004 Jun; 113(11):1571-81. PubMed ID: 15173883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of glucagon in hyperglycemia. A review (author's transl)].
    Luyckx A
    Diabete Metab; 1975 Sep; 1(3):201-8. PubMed ID: 791728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
    Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
    Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of glucagon to support postabsorptive glucose flux and glycemia in healthy rats and its attenuation in male Zucker diabetic fatty rats.
    Estes SK; Shiota C; O'Brien TP; Printz RL; Shiota M
    Am J Physiol Endocrinol Metab; 2024 Mar; 326(3):E308-E325. PubMed ID: 38265288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.